Tuberculosis (TB) is a major health problem in many countries and is primarily caused by organisms of the *Mycobacterium tuberculosis* complex (MTBC). However, the contribution of nontuberculous *Mycobacterium* (NTM) species to disease has also been reported and appears to depend on both environmental and host factors, leading to a variety of clinical symptoms ([@B12]). Despite being isolated frequently from environmental and human samples, NTM species were recognised as a cause of human disease only at the end of the fifties ([@B02] ). A re-evaluation of NTM species as disease-causing agents occurred due to the association of NTM infection with acquired immune deficiency syndrome (AIDS) and the recognition of NTM as the causative agent of lung disease in human immunodeficiency virus (HIV)-negative cases ([@B12] ). The clinical features of lung disease caused by NTM are often very similar to those of TB (Pedro et al. 2008). At present, over 150 different species of NTM have been described and NTM infections are emerging in scenarios not previously recognised, including in Brazil, with new clinical manifestations ([@B12]).

Outbreaks of NTM infections are increasing worldwide ([@B24]) and also in Brazil. Initially this was due to the HIV/AIDS pandemic, but now is apparently associated with surgery and cosmetic procedures due to the use of improperly sterilised equipment (MS 2008).

Rapid detection and identification of mycobacterium at the species level is important for the accurate selection and administration of antibiotics for infection and transmission control, particularly in immunosuppressed patients ([@B13]). The improvement in the techniques designed for mycobacterium identification in clinical laboratories has resulted in faster and more accurate identification of NTM on a larger scale and even directly in clinical samples ( [@B12]). Traditionally, the diagnosis of TB and NTM has depended on bacilloscopy and culturing in specific medium, but culture-based identification methods using biochemical tests are slow and inadequate to differentiate the growing list of mycobacterium species ([@B08]).

In Brazil, in the state of Rondônia (RO), mycobacterium culturing is not performed as a routine procedure for the diagnosis of TB in all symptomatic patients with negative sputum smears and there are no records of studies on NTM in RO. Therefore, our main objective was to study the frequency and diversity of NTM species present in pulmonary samples of patients with lung disease and evaluate their geographical distribution within the areas of occurrence in RO.

SUBJECTS, MATERIALS AND METHODS
===============================

*Patient isolates* - We performed a retrospective study using the laboratory data collected during routine processing of sputum samples obtained from individuals suspected of having pulmonary TB who were sent to the Central Laboratory of Public Health in RO (LACEN). Our study included 1,812 cultures obtained from 1,301 individuals who had at least one culture positive for mycobacterium and were either under investigation or being treated for disease between January 2008-December 2010. The laboratory data included the number and type of specimens collected, site of isolation, number of positive cultures obtained from the same case, identification of bacterial species as determined by conventional identification methods and HIV status of the patient. This study was approved by the Ethical Committee of the Federal University of Rondônia (protocol 19/2007).

*Sample processing, culturing and mycobacterium identification* - The samples were processed according to standard isolation techniques following the rules, regulations and recommendations described in the Manual for Tuberculosis Bacteriology of the Ministry of Health (MS 2005).

Distinction between MTBC and NTM species was determined by macroscopic and microscopic observation of cultures in Löwenstein-Jensen (LJ), the presence of cord factor and testing bacterial growth inhibition in medium containing 0.5 mg/mL para-nitrobenzoicacid (MS 2005). After characterisation of mycobacteria at the LACEN, the samples were sent to Reference Centre Professor Hélio Fraga at the National Reference Centre for Tuberculosis (Curicica, state of Rio de Janeiro) for species identification by polymerase chain reaction (PCR)-based restriction enzyme analysis (PRA) of a 441 bp fragment of the *hsp* 65 gene ([@B21]). In the samples with ambiguous PRA patterns, sequencing of the *hsp* 65 PCR products was performed as described previously ([@B15]).

The prevalence of NTM was defined as the number of individuals who presented at least one sample with a positive culture, while the microbiological criterion for pulmonary NTM as recommended by the American Thoracic Society (ATS) is obtaining positive cultures from at least two different samples of expectorated sputum.

RESULTS
=======

We analysed 1,812 respiratory secretion samples obtained from 1,301 individuals who were either suspected of having or were being treated for pulmonary TB. Among them, 444 (24.5%) yielded *Mycobacterium* growth in LJ, 369 (83.1%) were identified as belonging to the MTBC and 75 (16.9%) were NTM.

Among the 45 individuals who yielded the 75 NTM isolates, we received more than one sample from 24 cases and only two individuals did not have consistent positive culture-results (the 1st sample was positive and the 2nd was negative). The other 19 cases (46.7%) had positive cultures from either two (n = 12), three (n = 4), four (n = 2) or five (n = 1) consecutive samples and, according to the microbiological criteria defined by the ATS, were suffering from lung disease caused by NTM.

Among the 45 NTM-positive subjects, 29 (64.5%) were male and the subjects' age ranged from 12-78 years, with an average age of 50 years. Among the cases with TB caused by MTBC, 232 (72%) were male, with a median age of 36.7 years.

The RO comprises 52 municipalities and 24 of these municipalities sent out samples to perform *Mycobacterium* culture for a routine test as part of the National Tuberculosis Control Program. Of these, eight (33.3%) resulted in positive cultures for NTM ([Table I](#t01){ref-type="table"} ).

TABLE IDistribution of cases of *Mycobacterium tuberculosis* and nontuberculous *Mycobacterium* (NTM) in municipalities with higher occurrence in the state of Rondônia between 2008-2010Culture resultsPositiveNegativeMunicipalitiesTuberculosis n (%)NTM n (%)nTotal (n)Porto Velho296 (87.3)43 (12.7)8821,221Ji-Paraná15 (44.1)19 (55.9)134168Ariquemes15 (71.4)6 (28.6)6283Others43 (86)7 (14)290340Total369751,3681,812

Overall, the most frequent species throughout the state was identified as *Mycobacterium abscessus* (n = 24, 32%), followed by *Mycobacterium avium* (n = 13, 17.3%) and *Mycobacterium fortuitum* (n = 9, 12%). Thirteen NTM isolates (21%) remained unidentified because they could not be submitted for molecular identification.

In total, we identified 14 species of NTM, 12 isolated in Porto Velho (85.7%), six in Ji-Paraná (42.8%), two in Ariquemes (14.3%) and three in other districts (21.4%). We also evaluated regional mycobacterium species frequencies, as demonstrated in [Table II](#t02){ref-type="table"}.

TABLE IISpecies identification of 75 isolates nontuberculous *Mycobacterium* according to municipalities between 2008-2010MunicipalitiesSpeciesPorto Velho n (%)Ji-Paraná n (%)Ariquemes n (%)Others n (%)Total n*Mycobacterium abscessus*10 (23.3)8 (42)3 (50)3 (42.9)24*Mycobacterium avium*10 (23.3)-2 (33.3)1 (14.3)13*Mycobacterium fortuitum*4 (9.3)4 (21)-1 (14.3)9*Mycobacterium asiaticum*1 (2.3)\-\--1*Mycobacterium intracellulare*1 (2.3)3 (15.8)\--4*Mycobacterium gordonae*1 (2.3)1 (5.3)\--2*Mycobacterium szulgai*-1 (5.3)\--1*Mycobacterium tusciae*1 (2.3)\-\--1*Mycobacterium phlei*-1 (5.3)\--1*Mycobacterium simiae*1 (2.3)\-\--1*Mycobacterium novocastrense*1 (2.3)\-\--1*Mycobacterium gilvum*2 (4.6)\-\--2*Mycobacterium porcinum*1 (2.3)\-\--1*Mycobacterium holsaticum*1 (2.3)\-\--1Not identified9 (21)1 (5.3)1 (16.7)2 (28.6)13Total43196775

Sequencing was performed in two cases in which PRA- *hsp6* could not identify NTM at the species level. One isolate showed 99.75% identity with *M. avium* ATCC 25291 (GQ153289.1), while the other had 99.75% similarity with *Mycobacterium* *boenickei* CIP 107829 (107829). The isolate identified by PRA- *hsp65* as *Mycobacterium novocastrense* was confirmed by partial sequencing of the *hsp65* gene ([Table III](#t03){ref-type="table"}).

TABLE IIISpecies identification of isolates which had concordant results by phenotypic and polymerase chain reaction-based restriction enzyme analysis- *hsp65* methodsSamplesBSTEIIHAEIIIProfile compatible with*hsp65* gene sequencing(99.75% ID)157/08235/205160/145*Mycobacterium simiae* type 2-732/10235/205130/105*Mycobacterium avium* type 1-788/09235/205110/105*Mycobacterium asiaticum* type 1-1161/08235/205130/105*M. avium* type 1-1493/08235/205200/70/60/55*Mycobacterium abscessus* type 2-61/09235/115/85150/130/70*Mycobacterium tuberculosis* complex-198/08235/205145/130*M. avium* type 3 *ªM. avium* ATCC25291_GQ153289.1212/10440140/60/55*Mycobacterium novocastrense* type 1*M. novocastrense* CIP105546_AF547862.1708/10235/115/85150/130/70*M. tuberculosis* complex-725/10440130/105/100*Mycobacterium szulgai* type 1-826/10440140/100/60*Mycobacterium holsaticum* type 1-904/10235/205200/70/60/55*M. abscessus* type 2-1110/09235/115/85150/130/70*M. tuberculosis* complex-1254/09235/115/85150/130/70*M. tuberculosis* complex-188/08440175/90*Mycobacterium tusciae*-1603/08440180/145*Mycobacterium gilvum*-022/09235/205140/120/100New *^b^Mycobacterium boenickei* CIP 107829[^1]

DISCUSSION
==========

Unlike TB, notification of NTM-induced pulmonary disease is voluntary in Brazil and not confirmed by official records ([@B22], Pedro et al. 2008). In the present study, 16.9% of the *Mycobacterium* isolates were NTM and from our data, we calculated the incidence of NTM in 2010 as 3.9/100,000 and 10.8/100,000 in Porto Velho and Ji-Paraná, respectively, which is higher than the incidence of NTM-induced pulmonary disease reported in other studies conducted in Brazil. In an earlier study, [@B06] identified 51 NTM isolates positive for AFB in respiratory samples from 742 individuals (6.9%) diagnosed for pulmonary TB in the state of Pará (PA), in North Brazil, between 2004-2007. In another study performed in the same state over a 12-year period, 8% of TB cases were found to be caused by NTM ([@B07]). Although our study was also performed in the northern part of Brazil, we found that the NTM frequency was more than twice this value. Based on the analysis of samples from various regions of Brazil between 1994-1999, [@B01] reported that the majority of positive cultures (433, corresponding with 73.3%) for NTM were from pulmonary secretions.

The most frequently isolated NTM species in our samples were *M. abscessus* (32%), *M. avium* (17.3%) and *M. fortuitum* (12%). The species *Mycobacterium szulgai*, *M. novocastrense*, *Mycobacterium porcinum*, *Mycobacterium holsaticum*, *Mycobacterium asiaticum*, *Mycobacterium phlei* and *Mycobacterium simiae* were isolated only in Porto Velho and were not the same species found at a higher frequency in other states. In PA, the most frequent species were *Mycobacterium massiliense* (17.6%), *M. avium* (9.8%), *Mycobacterium colombiense* (9.8%), *Mycobacterium intracellulare* (9.8%) and *M. fortutuim* (7.8%) [@B06]. Generally, however, the most frequent species of NTM associated with lung disease in Brazil are *Mycobacterium kansasii* and *M. avium*, while species such as *Mycobacterium* *xenopi*, *Mycobacterium malmoense*, *Mycobacterium lentiflavum*, *M. abscessus* and *M. szulgai* are isolated occasionally ([@B01], [@B05]). However, most of the studies on the prevalence of NTM species have been conducted with residents of São Paulo, the country's largest metropolis. Analysis of pulmonary and extrapulmonary material sampled between 1991-1997 has established *M. avium* complex (MAC) (64.9%) as the most frequent species, followed by *M.* *kansasii* (12.2%) and *Mycobacterium* *gordonae* (10.2%), although *M. kansasii* was the most frequently isolated species from the lung (83%) ([@B22]). Pedro et al. (2008) evaluated 317 strains of NTM and identified 182 (57.4%) as MAC, 33 (10.4%) as *M. gordonae* , 25 (7.9%) as *M. fortuitum*, eight (2.5%) as *M. chelonae*, seven (2.2%) as *M. kansasii* and less prevalent species in 54 (17%) samples. [@B25] recently reported *M. kansasii* as the most prevalent NTM species (33.6%), higher than the MAC (17%) and *M. fortuitum* (13.4%). In the United States of America (USA), the most frequent NTM species associated with disease are MAC and other fast-growers, such as *M. abscessus*, *M. chelonae* and *M. fortuitum* ([@B04] ). In Asia, rapidly growing mycobacteria were found to cause 14% of pulmonary NTM infections, but in India, Taiwan and South Korea this frequency was found to be \> 30% ([@B20]). In England, where the frequency of NTM occurrence increased from 0.9/100,000 people in 1995 to 2.9/100,000 in 2006, the most commonly reported species was *M. avium-intracellulare,* which accounted for 43% of NTM cases, followed by *M. malmoense* (14%) and *M. kansasii* (13%). *M. gordonae* was reported to have the biggest percentage increase over the study period ([@B16]).

The rarely encountered *M. novocastrense* was identified by molecular methods and to the best of our knowledege, this is the first description of this species in Brazil. However, our sequencing method was also unable to identify of a number of isolates that could not be identified by PRA and this is currently being investigated further. In [Table III](#t03){ref-type="table"}, the PRA pattern of the strain characterised as *M.* *boenickei* was not as reported previously (PRASITE - app.chuv.ch/prasite/index.html), but this could be a new genetic variant and second PRA pattern of this less-frequently described species.

The fact that 12 of the 14 NTM species observed in the present study were isolated in Porto Velho is most likely because 67.4% of the samples were from that region. The difference in the NTM species predominating in this region (more *M. fortuitum* and *M. avium* compared with *M. abscessus* ) could be due to its geographical extent, including different biotopes and the larger population. In the study conducted in PA, [@B06] identified 12 different NTM species in respiratory specimens from 2004-2007. In another study in the state of São Paulo (SP), in the Santos region, [@B25] found 13 NTM species in 194 isolates sampled between 2000-2005.

The high prevalence of *M. abscessus* confirms that this species is more frequently associated with pulmonary disease than other NTM species and this could be due to its abundance in the environment, high pathogenicity and resistance to drugs used for TB treatment. Although *M. abscessus* is rarely isolated from soil or water, there is general agreement that it is widely present in such environments ([@B14], [@B23]). This species is especially problematic due to its resistance to many antibiotics ( [@B12]) and when identified in the respiratory tract, it is usually associated with significant pulmonary disease ([@B03]).

A higher relative frequency of NTM isolates was observed in Ji-Paraná in 2010 due to a frequency increase during the three-year period from 2008-2010 that was not observed in other regions of the state (data not shown). We currently have no explanation for this relatively higher NTM frequency in the region. This observation is also striking because only 4.3% of the cultures from this region could be analysed due to operational problems and, as demonstrated in the [Table II](#t02){ref-type="table"}, 42% of the cases had *M. abscessus* .

The fact that we received a second sample from only half of the cases demonstrates the difficulty of the health program in following up with patients. Other studies have also reported similar constraints. A study performed in Santos (SP) reported that 80.8% of subjects had only one positive culture test ([@B25]) and this is characteristic of developing countries in which limited resources often do not allow even culture isolation as a diagnostic option ([@B09]). However, a study in the USA that observed an increase in NTM also reported problems, such as the inability to examine clinical records of patients and distinguish temporary illness from colonisation ([@B12]). Given that 90.5% cases from which we obtained a second sample tested positive for NTM, it is very likely that this also is the case for subjects in which a second sample was unavailable. Therefore, the disease-causing frequency of NTM species in RO could be much higher than that deduced from our present data.

Among the 19 individuals who had at least two NTM-positive samples, two showed the presence of other species. The first case was an HIV-positive patient with one sample containing *M. simiae* and the second containing *M. avium.* The other case was an HIV-negative patient who presented three different NTM species in two samples. *M. fortuitum* was present in both samples, with *M. szulgai* in one case and *M. gordonae* in the other. We also observed three cases of NTM coinfection with *M. tuberculosis*, but the actual frequency of this phenomenon is unknown because all of the samples were investigated for the presence of the latter species. It has been shown that coinfection of NTM and *M. tuberculosis* is not infrequent but rarely diagnosed ([@B10]).

Empirical use of fluoroquinolones and other antitubercular drugs in relatively less-efficient health care settings creates a false impression of a low incidence of nontubercular cases ([@B11]). However, we observed a high frequency of NTM-causing pulmonary disease cases in RO. Because many NTM species are resistant to several antibiotics used for TB treatment and treatment scheme depends on the NTM species involved, a delay in the identification of NTM species and delays in distinguishing between MTBC and NTM can lead to inadequate treatment. Therefore, we suggest the implementation of rapid and precise methods for NTM species identification in RO.

To Adalberto Rezende Santos, Fiocruz/RJ, Francisco Ivan Braga Faig and Maria Helena Morais Dias, CEMETRON/RO, Raimunda Nonata Feitosa Rodrigues and Maria Luzinete Lopes Ribeiro, LACEN/RO, Ana Lúcia Teixeira, UBS/Ji-Paraná/RO and Nilda de Oliveira Barros, AGEVISA/RO.

[^1]: *a* : seven species with the same pattern: *Mycobacterium intracellulare* type 3, *M. avium s. avium* type 3, *Mycobacterium saskatchewanense* type 1, *Mycobacterium seoulense* type 1, *M. simiae* type 6, *Mycobacterium intermedium* type 1, *Mycobacterium interjectum* type 1; *b* : three species with the same score: *Mycobacterium porcinum* type 1, *Mycobacterium peregrinum* type 2 and *Mycobacterium septicum* type 1.
